Health

Results: 121-132 of 9480

ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT JULY 2026

PR Newswire associated0

APR Reports Record H1 2026 Revenue, Posts Highest-Ever Quarterly Results

PR Newswire associated0

Revolune and Propath UK Bring Service-Backed Multiplex immunofluorescence Workflows to Biopharma Customers

PR Newswire associated0

Revolune Announces Service Provider Program with CellCarta, Concept Life Sciences, and Propath UK

From left to right: Nasir Egal (General Manager, CDMO Services); Marie-Hélène Raigneau (Chief Executive Officer); Anuji Abraham (Senior Director, Pharmaceutical Development, CDMO Services); Robert Sabelli (Co-Chief Operating Officer); Cathy Konidas (Chief Administrative Officer)

Altasciences Completes Expansion of Research and Development Laboratory in Harleysville, Pennsylvania

PR Newswire associated0

TriNetX Supports European Healthcare Organizations on the Path to EHDS Readiness

PR Newswire associated0

Piramal Pharma Solutions Expands Peptide API Facility with Advanced Spray Drying Suite

Business Wire logo

LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care

Business Wire logo

Mosaic Therapeutics appoints Dr Allison Jeynes as Chair of the Board

Evexta Bio Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate Rupitasertib in Combination with a Selective Estrogen Receptor Degrader in Advanced / Metastatic Breast Cancer

4Moving Biotech completes enrollment in Phase 2a INFLAM MOTION study evaluating first-in-class intra-articular GLP-1 therapy targeting synovitis as a driver of pain and disease progression in knee osteoarthritis

4Moving Biotech Completes Enrollment in Phase 2a INFLAM MOTION Study Evaluating First-in-class Intra-articular GLP-1 Therapy Targeting Synovitis as a Driver of Pain and Disease Progression in Knee Osteoarthritis

PR Newswire associated0

Masimo Appoints Tim Benner as President